Sign In

Lou Beaulieu-Laroche

Biotech Investor | Stanford GSB MBA | MIT Neuroscience PhD

Lou Beaulieu-Laroche is a biotech analyst at Point72, currently based in the San Francisco Bay Area.1 His career journey has been marked by significant academic and professional achievements in the fields of neuroscience and biotechnology.

Academic Background

Lou completed his Ph.D. from the Massachusetts Institute of Technology (MIT) in 2021.2 During his time at MIT, he conducted groundbreaking research in neuroscience. His work culminated in a paper published in Nature, which he described as his highest scientific achievement and, interestingly, his last scientific publication.3

Career Transition

After completing his Ph.D., Lou made a transition from academia to the biotechnology industry. In June 2021, he announced that he would be joining Flagship Pioneering as a Venture Fellow.2 This move marked the beginning of his shift towards the business side of biotechnology.

Current Role

As of 2024, Lou Beaulieu-Laroche is working as a biotech analyst at Point72, a prominent asset management firm.1 This position allows him to leverage his deep scientific knowledge in the financial sector, analyzing biotechnology companies and trends.

Additional Education

In addition to his Ph.D., Lou has pursued further education to complement his transition into the business world. He attended Stanford University Graduate School of Business14, which likely provided him with the business acumen necessary for his current role in finance and biotechnology.

Research Contributions

During his academic career, Lou made significant contributions to neuroscience research. In November 2021, he was the lead author of a Nature paper that found striking differences between neurons of humans and other mammals.5 This study was conducted during his time as a graduate student at the McGovern Institute at MIT.

Lou Beaulieu-Laroche's career trajectory showcases a successful transition from academic research to the biotechnology industry and finance, combining his scientific expertise with business acumen in his current role at Point72.

Highlights

Nov 10 · linkedin

My paper is out in Nature!. This is my highest scientific achievement and strangely also my last scientific publication. I am now at Stanford University Graduate School of Business, acquiring new skills in order to lead organizations to effect change in the biotech industry.  In this article, I compared human neurons to 9 other mammalian species to reveal that human neurons exhibit unique biophysical features. These findings have important implications for understanding our outstanding cognitive abilities and the challenges therapies derived from animal models face in human clinical trials. https://lnkd.in/eNp-uqMj #neuroscience #research #biotech

Jun 5 · linkedin

Yesterday I officially received my PhD from Massachusetts Institute of Technology! I’m thrilled to announce that I will be joining Flagship Pioneering this summer as a Venture Fellow and will then attend Stanford University Graduate School of Business for an MBA. Thank you to everyone who has shared their journey with me and helped me make this transition. I’m really excited for the next steps!

Related Questions

What are Lou Beaulieu-Laroche's main responsibilities at Point72?
What was the focus of Lou Beaulieu-Laroche's PhD research at MIT?
How did Lou Beaulieu-Laroche's work at MIT contribute to the field of neuroscience?
What is Lou Beaulieu-Laroche's role at Flagship Pioneering?
Can you provide more details about Lou Beaulieu-Laroche's paper published in Nature?
Lou Beaulieu-Laroche
Lou Beaulieu-Laroche, photo 1
Lou Beaulieu-Laroche, photo 2
Add to my network

Location

San Francisco Bay Area